KR20160102949A - Novel compounds for organic electroluminescent device - Google Patents

Novel compounds for organic electroluminescent device Download PDF

Info

Publication number
KR20160102949A
KR20160102949A KR1020160106252A KR20160106252A KR20160102949A KR 20160102949 A KR20160102949 A KR 20160102949A KR 1020160106252 A KR1020160106252 A KR 1020160106252A KR 20160106252 A KR20160106252 A KR 20160106252A KR 20160102949 A KR20160102949 A KR 20160102949A
Authority
KR
South Korea
Prior art keywords
compound
mmol
fluorene
group
independently
Prior art date
Application number
KR1020160106252A
Other languages
Korean (ko)
Inventor
구영삼
김정태
Original Assignee
(주) 에프엔지리서치
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주) 에프엔지리서치 filed Critical (주) 에프엔지리서치
Priority to KR1020160106252A priority Critical patent/KR20160102949A/en
Publication of KR20160102949A publication Critical patent/KR20160102949A/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C15/00Cyclic hydrocarbons containing only six-membered aromatic rings as cyclic parts
    • C07C15/12Polycyclic non-condensed hydrocarbons
    • C07C15/14Polycyclic non-condensed hydrocarbons all phenyl groups being directly linked
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/10Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • C07D231/20One oxygen atom attached in position 3 or 5
    • C07D231/22One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms
    • C07D231/261-Phenyl-3-methyl-5- pyrazolones, unsubstituted or substituted on the phenyl ring
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3441Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom
    • C09K19/345Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom the heterocyclic ring being a six-membered aromatic ring containing two nitrogen atoms
    • C09K19/3458Uncondensed pyrimidines
    • C09K19/3469Pyrimidine with a specific end-group other than alkyl, alkoxy or -C*-

Abstract

Provided is a compound which is represented by chemical formula 1, and is used to manufacture an organic electroluminescent device. According to the present invention, the compound has high hole mobility, high thermal stability, a high band gap energy, a high energy level between a hole injection layer and a luminous layer, a low LUMO value, non-crystallinity, and the like, thereby being useful to a hole transfer material.

Description

유기전계발광 소자 제조용 신규 화합물{Novel compounds for organic electroluminescent device}TECHNICAL FIELD [0001] The present invention relates to a novel compound for organic electroluminescent device,

본 발명은 유기전계발광 소자의 제조에 이용되는 화합물에 관한 것으로, 보다 상세히는 정공수송재료로 유용하게 이용될 수 있는 신규한 유기 화합물에 관한 것이다.BACKGROUND OF THE INVENTION 1. Field of the Invention [0001] The present invention relates to a compound used in the production of an organic electroluminescent device, and more particularly, to a novel organic compound which can be usefully used as a hole transporting material.

유기전계발광소자(Organic electroluminescent device)는 형광성 유기 화합물에 전류가 흐르면 스스로 빛을 내는 자체 발광형 유기물질을 말하며, 유기발광다이오드(Organic Light Emitting Diodes, 이하 'OLED')로도 지칭된다.An organic electroluminescent device refers to a self-emitting organic material that emits light when a current flows through a fluorescent organic compound, and is also referred to as an organic light emitting diode (OLED).

OLED는 종래 디스플레이 소자로 이용되는 LCD(Liquid Crystal Display), PDP(Plasma Display Panel) 등에 비해 반응속도(응답속도), 휘도, 시야각, 콘트라스트, 소비전력 등의 물성에서 매우 우수하여 차세대 디스플레이 소자로 주목받아 왔다. 초기에는 수동형 OLED (Passive Matrix OLED; PMOLED) 형태로 개발되어 휴대폰과 같은 소형 디스플레이 소자로 양산되었으나, 지속적인 기술 개발을 통해 최근에는 능동형 OLED (Active Matrix OLED; AMOLED)를 이용한 대형 TV 양산을 앞두고 있다.OLEDs are excellent in properties such as reaction speed (response speed), luminance, viewing angle, contrast, power consumption, etc., compared to LCD (Liquid Crystal Display) and PDP (Plasma Display Panel) I have received. In the early days, it was developed as a passive matrix OLED (PMOLED), and it was mass produced as a small display device such as a mobile phone. However, it is in the process of mass production of an active matrix OLED (AMOLED).

OLED의 전계발광 현상은 1963년 Pope, Kallmann, Magnete 에 의해 안트라센 결정에서 처음 발견되었으나, 400V 이상의 높은 구동 전압이 요구되며, 발광 효율(약 0.05% 이하)도 아주 낮아 실용화에 어려움이 있었다.The electroluminescence phenomenon of OLEDs was first found in anthracene crystals by Pope, Kallmann, and Magnete in 1963, but it required a high driving voltage of 400V or more, and the luminous efficiency (about 0.05% or less) was very low.

1987년 C. W. Tang과 S. A. VanSlyke는 양극과 Mg-Ag 합금으로 된 음극 사이에 디아민을 정공수송층(HTL)으로 하고, 녹색 유기 발광물질인 트리스-8(하이드로퀴놀린)알루미늄(Alq3)을 발광층 및 전자수송층으로 하여 각각 약 50nm 정도의 아주 얇은 박막으로 적층하여 10V 이하의 낮은 구동 전압에서도 1,000cd/m2 이상의 휘도와 1.5 lm/W 수준의 높은 발광 효율을 나타내는 녹색 OLED 소자를 개발하였다(C.W. Tang, App. Phys. Lett. 1986, 48, 183; C.W. Tang and S.A. VanSlyke, App. Phys. Lett. 1987, 51, 913; A. Tsumura, et. al., App. Phys. Lett. 1986, 49, 1210). 상기 방법은 고휘도, 고효율의 차세대 디스플레이의 개발 가능성을 제시한 것으로, 현재까지 대표적인 OLED 제작 기법으로 이용되고 있다.1987 CW Tang and VanSlyke SA is a tris-8 (tetrahydro-quinoline) Aluminum (Alq 3) emission layer, and an electron anode and Mg-Ag alloy with a diamine between the anode as a hole transport layer (HTL), and a green organic light emitting material Transport layer with a thickness of about 50 nm and developed a green OLED device that exhibits a luminance of more than 1,000 cd / m 2 and a high luminescence efficiency of 1.5 lm / W even at a driving voltage of 10 V or less (CW Tang, 1986, 49, 1210, 1987, 51, 913; A. Tsumura, et al., App. Phys. Lett. 1986, 48, 183; CW Tang and SA VanSlyke, ). The above-described method shows the possibility of developing a high-brightness, high-efficiency next-generation display, and has been used as a typical OLED manufacturing technique to date.

오늘날 OLED는 도 1 및 도 2에서와 같은 다층 구조로 정립되어 있다. OLED는 음극(Cathode), 전자주입층(Electron Injection Layer; EIL), 전자수송층(Electron Transfer Layer; ETL), 발광층(Emission Material Layer; EML), 정공수송층(Hole Transfer Layer; HTL), 정공주입층(Hole Injection Layer; HIL), 양극(Anode), 투명기판(Glass)으로 구성된다. 전원이 공급되면 음극(Cathode)에서는 전자(-)가 전자수송층(Electron Transfer Layer; ETL)의 도움으로 유기물질인 발광층(Emission Material Layer; EML)으로 이동하고, 양극(Anode)에서는 정공(+)이 정공수송층(Hole Transfer Layer; HTL)의 도움으로 발광층(Emission Material Layer; EML)으로 이동하게 되어 발광층에서 만난 전자와 정공이 재결합하면서 여기자(exciton)를 형성하고 여기자가 기저상태(ground state)로 전이하면서 방출되는 에너지는 특정 파장의 빛으로 전환되어 발광된다.Today, OLEDs are formed in a multi-layer structure as in FIGS. 1 and 2. The OLED includes a cathode, an electron injection layer (EIL), an electron transfer layer (ETL), an emission material layer (EML), a hole transport layer (HTL) A hole injection layer (HIL), an anode, and a transparent substrate (Glass). When power is supplied, electrons in the cathode migrate to the emission material layer (EML), which is an organic material, with the help of an electron transfer layer (ETL) (EML) with the help of a hole transport layer (HTL) to recombine electrons and holes in the light emitting layer to form an exciton and to excite the excitons to a ground state The energy released during the transition is converted to light of a specific wavelength and emitted.

OLED에 사용되는 모든 재료들의 바람직한 특성은 진공증착이 가능하도록 적당한 분자량을 가져야 하고, 유리전이온도(Tg)와 열분해온도(Td)에서 높은 열안정성을 나타내야 하며 소자 작동시 발생하는 주울(Joule) 열로 야기되는 결정화에 의해 소자가 파괴되지 않도록 무정형이어야 하며 인접층과의 접착력은 좋은 반면 다른 층으로 이동되지 않아야 한다.The desirable characteristics of all the materials used in OLEDs are that they should have a suitable molecular weight to enable vacuum deposition and exhibit high thermal stability at a glass transition temperature (Tg) and a thermal decomposition temperature (Td), and as Joule heat It should be amorphous so that the device is not destroyed by the crystallization caused and the adhesion to the adjacent layer should be good but not to the other layer.

정공수송층(HTL)에 이용되는 재료는 정공주입층으로부터 유입되는 정공을 빠르게 발광층으로 운반시킬 뿐만 아니라 전자를 발광층 내에 속박함(bound)으로서 여기자 형성 확률을 높여준다. 이러한 정공수송재료는 정공 이동도가 빨라야 하고 정공수송층-발광층 계면에서의 여기자 발생을 억제하기 위해서 이온화 레벨이 정공주입층과 발광층 사이의 값을 가지고, 밴드갭(band gap)이 큰 것이 바람직하다(도 2 참조). 또한 발광층으로부터 전자가 정공수송층으로 이동되지 못하도록 제어하는 능력 및 내열성, 내구성 등의 기계적 물성이 요구된다.The material used for the hole transport layer (HTL) not only rapidly transports holes injected from the hole injection layer to the light emitting layer, but also bounds electrons in the light emitting layer, thereby increasing the probability of forming an exciton. The hole transporting material preferably has a high hole mobility and has an ionization level between the hole injection layer and the light emitting layer and has a large band gap in order to suppress exciton generation at the interface between the hole transporting layer and the light emitting layer 2). The ability to control electrons from moving from the light emitting layer to the hole transporting layer, and mechanical properties such as heat resistance and durability.

정공수송재료가 가져야 할 특성을 요약하면 다음과 같다.The characteristics of hole transport materials should be summarized as follows.

- 높은 정공 이동도- High hole mobility

- 정공주입층과 발광층 사이의 에너지 레벨The energy level between the hole injection layer and the light emitting layer

- 전자 블록킹을 위한 낮은 LUMO 값- Low LUMO value for electronic blocking

- 결정성 없는 박막- Crystalline thin film

- 높은 열안정성- High thermal stability

- 높은 밴드갭 에너지- High band gap energy

정공수송재료에 요구되는 상기 물성은 OLED의 수명 및 고효율화에 직결된다.The physical properties required for the hole transporting material are directly related to the lifetime and the high efficiency of the OLED.

트리페닐아민 구조는 정공 이동도가 우수한 것으로 알려져 트리페닐아민 구조를 기본 골격으로 한 디아민, 트리아민 및 테트리아민 유도체가 정공수송재료로 많이 개발되고 있다. 초기에는 TPD(Triphenyldiamine)이 이용되었으나 가장 중요한 특성 중 하나인 유리전이온도가 60℃로 낮아 열안정성 면에서 취약하였다. 이러한 열안정성을 향상시키기 위해 트리페닐아민 골격의 화학단위를 늘리거나 α-NPD, spiro-TTB 등과 같이 다환 구조로 분자량이 확대된 유도체들이 주로 개발되었다.Triphenylamine structure is known to have excellent hole mobility, and diamine, triamine, and tetramine derivatives having a triphenylamine structure as a basic skeleton are widely used as hole transport materials. Initially TPD (Triphenyldiamine) was used but its glass transition temperature, which is one of the most important characteristics, was low at 60 ℃, which was weak in terms of thermal stability. In order to improve the thermal stability, derivatives having a larger molecular weight, such as α-NPD, spiro-TTB, etc., have been developed mainly by increasing the chemical unit of the triphenylamine skeleton.

개발된 대표적인 정공수송재료들을 아래에 나타내었다.Representative hole transport materials developed are shown below.

Figure pat00001
Figure pat00001

Figure pat00002
Figure pat00002

Figure pat00003
Figure pat00003

Figure pat00004
Figure pat00004

Figure pat00005
Figure pat00005

전술한 바와 같이 OLED 디스플레이의 장수명, 높은 전력효율을 위해 정공수송재료는 정공 이동도, 열안정성, 밴드갭 에너지가 높아야 하고, 정공주입층과 발광층 사이의 에너지 레벨, 낮은 LUMO 값, 비결정성을 가져야 하며, 이러한 물성을 보다 충족시키는 새로운 재료 개발이 요구되고 있다.As described above, for the long life and high power efficiency of the OLED display, the hole transporting material should have high hole mobility, thermal stability, band gap energy, energy level between the hole injection layer and the light emitting layer, low LUMO value, and amorphous And development of a new material that satisfies these properties is required.

본 발명은 높은 정공 이동도, 열안정성, 높은 밴드갭 에너지, 정공주입층과 발광층 사이의 에너지 레벨, 낮은 LUMO 값, 비결정성 등 정공수송재료에 요구되는 개선된 물성을 가진 신규 화합물을 제공하는 데 있다.The present invention provides a novel compound having high hole mobility, thermal stability, high band gap energy, energy level between the hole injection layer and the light emitting layer, low LUMO value, and improved physical properties required for hole transport materials such as amorphous have.

또한, 본 발명은 필요에 따라서는 발광재료로 이용되는 상기 신규 화합물을 제공하는 데 있다.Further, the present invention is to provide the novel compound, which is used as a light emitting material if necessary.

또한, 본 발명은 상기 화합물로부터 형성된 정공수송층 또는 발광층을 포함하는 유기전계발광 소자를 제공하는 데 있다.The present invention also provides an organic electroluminescent device including a hole transporting layer or a light emitting layer formed from the above compound.

상기 목적을 해결하기 위하여, 본 발명은 하기 화학식 I로 표시되는 유기 전계 발광 소자용 화합물을 제공한다.In order to solve the above-mentioned object, the present invention provides a compound for organic electroluminescent device represented by the following general formula (I).

[화학식 1][Chemical Formula 1]

Figure pat00006
Figure pat00006

(상기 식에서,(Wherein,

-Z-는 단일 결합(-), -CR5R6-, -CR5R6-CR5R6-, -CR5=CR6-, -O-, -S-, >N-R5 또는 >C=O이고,-Z- represents a single bond (-), -CR 5 R 6 -, -CR 5 R 6 -CR 5 R 6 -, -CR 5 = CR 6 -, -O-, -S-,> NR 5 or> C = O,

R1, R2, R3, R4, R5 및 R6은 각각 독립적으로, 수소원자 또는 C1~C15의 직쇄 또는 측쇄 알킬기이고, R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are each independently a hydrogen atom or a C 1 to C 15 linear or branched alkyl group,

m, n, p, q는 각 벤젠고리의 치환 갯수로서 각각 독립적으로 0, 1, 2, 3 또는 4이고,m, n, p, and q are independently the number of substituents of each benzene ring, 0, 1, 2, 3 or 4,

Ar1, Ar2는 각각 독립적으로, 치환되지 않거나 C1~C15의 직쇄 또는 측쇄 알킬기로 치환된 페닐기; 치환되지 않거나 C1~C15의 직쇄 또는 측쇄 알킬기로 치환된 비페닐기; 치환되지 않거나 C1~C15의 직쇄 또는 측쇄 알킬기로 치환된 플루오렌기이다.)Ar 1 and Ar 2 are each independently a phenyl group which is unsubstituted or substituted with a C 1 to C 15 linear or branched alkyl group; A biphenyl group which is unsubstituted or substituted with a linear or branched alkyl group having 1 to 15 carbon atoms; A fluorene group which is unsubstituted or substituted by a C 1 -C 15 linear or branched alkyl group.)

상기 화학식 I의 화합물은 바람직하게는 정공수송재료로 이용될 수 있다.The compound of formula (I) may preferably be used as a hole transporting material.

본 발명에 따른 신규 유기화합물은 높은 정공 이동도, 열안정성, 높은 밴드갭 에너지, 정공주입층과 발광층 사이의 에너지 레벨, 낮은 LUMO 값, 비결정성 등을 가져 정공수송재료에 유용하게 이용될 수 있다.The novel organic compound according to the present invention has high hole mobility, thermal stability, high band gap energy, energy level between the hole injection layer and the light emitting layer, low LUMO value, amorphous property, etc., .

따라서, 본 발명의 화합물을 이용한 OLED 디스플레이는 높은 전력효율과 수명을 가지는 효과가 있다.Therefore, the OLED display using the compound of the present invention has a high power efficiency and a long service life.

도 1은 유기전계발광 소자의 다층 구조를 나타낸 모식도이다.
도 2는 유기전계발광 소자의 발광 원리를 나타낸 모식도이다.
도 3은 본 발명에 따른 유기전계발광 소자용 화합물의 화학식을 나타낸 것이다.
1 is a schematic view showing a multilayer structure of an organic electroluminescent device.
2 is a schematic diagram showing the principle of luminescence of an organic electroluminescent device.
3 shows the formula of the compound for organic EL device according to the present invention.

이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.

본 발명자들은 스피로 다환 구조 화합물과 9-페닐카바졸 유도체가 아민 결합된 특정한 아릴 아민 유도체가 유기전계발광 소자, 특히 전공수송재료로 유용하게 이용될 수 있음을 확인하여 본 발명을 완성하게 되었다.The present inventors have completed the present invention by confirming that a specific arylamine derivative in which a spirocyanide structure compound and a 9-phenylcarbazole derivative are amine-bonded can be usefully used as an organic electroluminescent device, particularly a mobility material.

본 발명은 하기 화학식 I로 표시되는 유기전계발광 소자용 화합물을 제공한다.The present invention provides a compound for an organic electroluminescence device represented by the following general formula (I).

[화학식 I](I)

Figure pat00007
Figure pat00007

(상기 식에서,(Wherein,

-Z-는 단일 결합(-), -CR5R6-, -CR5R6-CR5R6-, -CR5=CR6-, -O-, -S-, >N-R5 또는 >C=O이고,-Z- represents a single bond (-), -CR 5 R 6 -, -CR 5 R 6 -CR 5 R 6 -, -CR 5 = CR 6 -, -O-, -S-,> NR 5 or> C = O,

R1, R2, R3, R4, R5 및 R6은 각각 독립적으로, 수소원자 또는 C1~C15의 직쇄 또는 측쇄 알킬기이고, R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are each independently a hydrogen atom or a C 1 to C 15 linear or branched alkyl group,

m, n, p, q는 각 벤젠고리의 치환 갯수로서 각각 독립적으로 0, 1, 2, 3 또는 4이고,m, n, p, and q are independently the number of substituents of each benzene ring, 0, 1, 2, 3 or 4,

Ar1, Ar2는 각각 독립적으로, 치환되지 않거나 C1~C15의 직쇄 또는 측쇄 알킬기로 치환된 페닐기; 치환되지 않거나 C1~C15의 직쇄 또는 측쇄 알킬기로 치환된 비페닐기; 치환되지 않거나 C1~C15의 직쇄 또는 측쇄 알킬기로 치환된 플루오렌기이다.)Ar 1 and Ar 2 are each independently a phenyl group which is unsubstituted or substituted with a C 1 to C 15 linear or branched alkyl group; A biphenyl group which is unsubstituted or substituted with a linear or branched alkyl group having 1 to 15 carbon atoms; A fluorene group which is unsubstituted or substituted by a C 1 -C 15 linear or branched alkyl group.)

본 발명에 따른 상기 화합물은 스피로플루오렌계 유도체와 9-페닐카바졸 유도체가 아민으로 연결된 트리아릴아민 유도체인 것을 특징으로 한다.The compound according to the present invention is characterized in that the spirofluorene derivative and the 9-phenylcarbazole derivative are triarylamine derivatives linked by an amine.

본 발명에 있어 스피로플루오렌계 유도체는 벤젠고리 상호간 결합안정성을 향상시키기 위해 플루오렌에 대향되는 벤젠고리 끼리 고리화된 것을 특징으로 하며, 상기 고리화는 단일 결합(벤젠간 직접 결합) 또는 C1~C2의 알킬, 알켄기 또는 케톤기로 결합되거나, O, S, N 원자로 결합되는 것을 특징으로 한다. 상기 고리화는 공액 이중결합(conjugated double bond)에 영향을 주지 않으면서 화합물의 정공수송 능력 및 내열성, 내구성을 향상시킨다.In the present invention, the spirofluorene derivative is characterized in that the benzene rings opposite to the fluorene are cyclized to improve the binding stability between the benzene rings, and the cyclization is a single bond (direct bond between benzene) or C 1 ~ C 2 alkyl, or combine know alkene group or ketone, characterized in that the bond O, S, N atoms. The cyclization enhances the hole transporting ability, heat resistance and durability of the compound without affecting the conjugated double bond.

상기 스피로플루오렌 유도체는 스피로비플루오렌, 스피로(플루오렌-크산텐), 스피로(플루오렌-9,10-디하이드로-10,10-디알킬안트라센), 스피로(플루오렌-티오크산텐), 스피로(플루오렌-10,11-디하이드로-5H-디벤조[a,d]시클로헵텐), 스피로(플로오렌-5H-디벤조[a,d]시클로헵텐), 스피로(플루오렌-10-알킬-10H-아크리딘), 스피로(플루오렌-안트라센-10-온) 등에서 선택될 수 있다.The spirofluorene derivatives include spirofluorene, spiro (fluorene-xanthene), spiro (fluorene-9,10-dihydro-10,10-dialkyl anthracene), spiro (fluorene- Dibenzo [a, d] cycloheptene), spiro (fluorene-5H-dibenzo [a, d] cycloheptene), spiro (fluorene-10 -Alkyl-10H-acridine), spiro (fluorene-anthracene-10-one), and the like.

본 발명에 있어 벤젠고리에 치환된 R1 내지 R11은 수소원자 또는, C1~C15의 직쇄 또는 측쇄 알킬기이다. 상기 치환기는 공액 이중결합에 영향을 주지않으므로 기본 골격 구조와 정공수송 능력에서는 큰 차이가 없다. 상기 알킬기의 구체예로서는, 메틸기, 에틸기, 프로필기, 이소프로필기, 부틸기, sec-부틸기, tert-부틸기, 펜틸기, 헥실기, 헵틸기, 옥틸기 등이고, 아민 유도체의 진공증착법에 의한 성형 안정성을 고려할 때, C1~C6의 알킬기인 것이 바람직하고, 치환되지 않거나(수소원자) 또는 메틸기(C1)인 것이 더욱 바람직하다.In the present invention, R 1 to R 11 substituted on the benzene ring are hydrogen atoms or C 1 to C 15 linear or branched alkyl groups. Since the substituent does not affect the conjugated double bond, there is no significant difference in the basic skeletal structure and hole transporting ability. Specific examples of the alkyl group include a methyl group, an ethyl group, a propyl group, an isopropyl group, a butyl group, a sec-butyl group, a tert-butyl group, a pentyl group, a hexyl group, a heptyl group, In consideration of the molding stability, it is preferably an alkyl group having 1 to 6 carbon atoms, more preferably a hydrogen atom or a methyl group (C 1 ).

밴드갭 에너지, 에너지 레벨, LUMO 값을 고려할 때 상기 화학식 I에서 Ar1과 Ar2의 벤젠고리의 합이 3인 것이 바람직하다. 즉, 하기 화학식 Ⅱ에 표시된 바와 같이 Ar1이 비페닐기 또는 이의 유도체인 경우 Ar2은 페닐기로 이루어지는 것이 바람직하고, 하기 화학식 Ⅲ에 표시된 바와 같이 Ar1이 페닐기인 경우 Ar2은 비페닐기 또는 이의 유도체인 것이 바람직하다.Considering the band gap energy, the energy level and the LUMO value, the sum of the benzene rings of Ar 1 and Ar 2 in the formula (I) is preferably 3. That is, when Ar 1 is a biphenyl group or a derivative thereof, as shown in the following formula (II), Ar 2 is preferably a phenyl group, and when Ar 1 is a phenyl group, Ar 2 is a biphenyl group or derivative thereof .

[화학식 Ⅱ][Formula II]

Figure pat00008
Figure pat00008

[화학식 Ⅲ][Formula (III)

Figure pat00009
Figure pat00009

(상기 식에서,(Wherein,

-Z-는 단일 결합(-), -CR5R6-, -CR5R6-CR5R6-, -CR5=CR6-, -O-, -S-, >N-R5 또는 >C=O이고,-Z- represents a single bond (-), -CR 5 R 6 -, -CR 5 R 6 -CR 5 R 6 -, -CR 5 = CR 6 -, -O-, -S-,> NR 5 or> C = O,

점선은 존재하지 않거나 -CR10R11- 이고,The dotted line is absent or -CR < 10 > R < 11 &

상기 R1, R2, R3, R4, R5, R6, R7, R8, R9, R10 및 R11 은 각각 독립적으로, 수소원자 또는 C1~C15의 직쇄 또는 측쇄 알킬기이고, Each of R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 and R 11 is independently a hydrogen atom or a C 1 to C 15 linear or branched Alkyl group,

m, n, p, q, s, t는 각 벤젠고리의 치환 갯수로서 각각 독립적으로, 0, 1, 2, 3 또는 4이고, r은 0, 1, 2, 3, 4 또는 5이다.)m, n, p, q, s, and t are independently 0, 1, 2, 3 or 4 and r is 0, 1, 2, 3, 4 or 5,

상기 화학식 I의 화합물은 하기 반응식 1에 따라 합성될 수 있다. 다만, 하기 반응식 I은 바람직한 합성 방법을 예시한 것으로, 공지의 다른 합성법의 조합으로 제조될 수도 있으며, 아민 반응의 순서는 제한되지 않는다.The compound of formula (I) can be synthesized according to the following reaction formula (1). However, the following Reaction Scheme I illustrates a preferred synthesis method, which may be prepared by a combination of other well-known synthetic methods, and the order of the amine reaction is not limited.

[반응식 1][Reaction Scheme 1]

Figure pat00010
Figure pat00010

2-브로모비페닐을 Mg 분말을 사용하여 그리냐르 시약을 제조한 후 디벤조 시클로케톤 화합물(화합물 a)과 반응시킨 후 산 조건 하에서 반응시키거나, n-BuLi(부틸리튬) 조건 하에서 반응시킨 후 산 조건 하에서 반응시켜 스피로플루오렌 유도체(화합물 b)를 합성한다.Bromobiphenyl is reacted with a dibenzocycloalkane compound (compound a) after the Grignard reagent is prepared using Mg powder and then reacted under an acidic condition or reacted under n-BuLi (butyl lithium) condition Under an acid condition to synthesize a spirofluorene derivative (compound b).

상기 제조된 스피로플루오렌 유도체(화합물 b)에 질산 또는 질산/황산의 혼산으로 반응시켜 아미노 화합물(화합물 c)을 합성한 다음, 고압 하에서 수소화 반응시켜 1차 아민 화합물(화합물 d)을 합성한다.An amino compound (compound c) is synthesized by reacting the spirofluorene derivative (compound b) prepared above with nitric acid or a mixed acid of nitric acid / sulfuric acid to synthesize an amino compound (compound c) and then hydrogenation reaction under high pressure to synthesize a primary amine compound (compound d).

상기 제조된 1차 아민 화합물(화합물 d)를 Ar1-Br(화합물 e)과 아민 반응시켜 2차 아민 화합물(화합물 f)를 합성한다. 이때 1차 아민에 Ar1이 두개 결합되는 것을 방지하기 위하여 화합물 d는 Ar1-Br 에 대해 1.3 당량 이상 사용되는 것이 바람직하다.The thus prepared primary amine compound (compound d) is reacted with Ar 1 -Br (compound e) to give a secondary amine compound (compound f). In this case, in order to prevent two Ar 1 from bonding to the primary amine, the compound d is preferably used in an amount of at least 1.3 equivalents based on Ar 1 -Br.

상기 제조된 2차 아민 화합물(화합물 f)을 페닐카바졸 유도체 화합물(화합물 g)와 아민 반응시켜 목적 화합물(화합물 h)를 합성한다.The desired secondary amine compound (compound f) is reacted with a phenylcarbazole derivative compound (compound g) by an amine to synthesize the desired compound (compound h).

이하, 실시예를 통하여 본 발명을 상세히 설명한다. 다만, 하기 실시예는 본 발명의 기술적 사상을 설명하기 위한 것으로, 본 발명이 하기 실시예에 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail by way of examples. However, the following examples are intended to illustrate the technical concept of the present invention, and the present invention is not limited to the following examples.

실시예 1: N-비페닐-4-일-N-(4-(9-페닐-9H- 카바졸 -3-일)-페닐)- 스피로비플루 오렌-2-아민의 합성: (화합물 5) Example 1: N- biphenyl-4-yl -N- (4- (9- phenyl -9H- carbazol-3-yl) phenyl) fluorene RY lobby Synthesis of fluoren-2-amine (compound 5 )

하기 반응식 2에 따라 합성을 진행하였다.Synthesis was carried out according to Reaction Scheme 2 below.

[반응식 2][Reaction Scheme 2]

Figure pat00011
Figure pat00011

(A) 9,9'-스피로비플루오렌의 합성: (화합물 1)(A) Synthesis of 9,9'-spirobifluorene: (Compound 1)

2-브로모비페닐 46.4g(200mmol), 마그네슘 분말(Magnesium turning) 5.3g, dry THF 900ml를 3구 플라스크에 넣고 4시간 동안 환류한다. 플루오레논(fluorenone) 36.0g(200mmol)을 dry THF 300ml에 녹여 천천히 적가한 후 2시간 동안 환류한다. 약 10℃로 냉각하여 1N HCl 200ml을 넣고 30분간 교반 후 THF를 농축하고 물 1000ml를 넣고 교반하여 여과한다. 상기 여과한 고체를 톨루엔에 녹여 MgSO4로 남아 있는 물을 제거하고 중성활성탄 7.0g을 넣고 30분 교반 후 여과하여 농축한다. 상기 농축 잔사에 시클로헥산 400ml을 넣고 1시간 동안 교반 후 상온 냉각하여 여과한다. 상기 여과한 고체에 아세트산 200ml와 진한 염산 1ml를 넣고 5시간 동안 교반한다. 냉각하여 상온에서 메탄올 200ml을 투입하고 30분 교반 후 여과한다. 상기 여과한 고체를 메탄올에서 재결정하여 표제화합물 44.9g(142 mmol)의 고체를 얻었다.(수율 71%)46.4 g (200 mmol) of 2-bromobiphenyl, 5.3 g of magnesium powder and 900 ml of dry THF were placed in a three-necked flask and refluxed for 4 hours. 36.0 g (200 mmol) of fluorenone is dissolved in 300 ml of dry THF, and the solution is slowly added dropwise thereto, followed by refluxing for 2 hours. Cool to about 10 ° C, add 200 ml of 1N HCl, stir for 30 minutes, concentrate THF, add 1000 ml of water, stir and filter. The filtered solid was dissolved in toluene, and the water remaining with MgSO 4 was removed. 7.0 g of neutral activated carbon was added and stirred for 30 minutes, followed by filtration and concentration. 400 ml of cyclohexane is added to the concentrated residue, stirred for 1 hour, cooled at room temperature and filtered. To the filtered solid was added 200 ml of acetic acid and 1 ml of concentrated hydrochloric acid, and the mixture was stirred for 5 hours. Cool, add 200 ml of methanol at room temperature, stir for 30 minutes, and filter. The filtrate solid was recrystallized from methanol to obtain 44.9 g (142 mmol) of the title compound as a solid (yield: 71%).

(B) 2-니트로-9,9'-스피로비플루오렌의 합성: (화합물 2)(B) Synthesis of 2-nitro-9,9'-spirobifluorene: (Compound 2)

상기 수득된 화합물1(44.9g)을 MC 250ml에 녹인 후 10℃로 냉각한다. HNO3 20g과 H2SO4 9g을 섞어 만든 혼산을 1시간에 걸쳐 서서히 적가한 후 10~15℃을 유지하면서 3시간 동안 교반한다. 층분리하여 혼산을 제거하고 Na2CO3 8.5g을 물 150ml에 녹여 투입하고 교반한다. 셀라이트(Celite)로 여과하여 불순물을 제거하고 층분리한다. MC층을 MgSO4를 이용하여 물을 제거하고, 중성활성탄 10g을 투입하여 30분 교반 후 여과 농축한다. 메탄올로 재결정하여 표제화합물 40.5g(112 mmol)의 고체를 얻었다.(수율 79%)The obtained Compound 1 (44.9 g) was dissolved in 250 ml of MC and then cooled to 10 ° C. The mixed acid prepared by mixing 20 g of HNO 3 and 9 g of H 2 SO 4 is gradually added dropwise over 1 hour, and the mixture is stirred at 10 to 15 ° C for 3 hours. Separation to remove the mixed acid layer and Na 2 CO 3 Is dissolved in 150 ml of water, and the mixture is stirred. Filter with Celite to remove impurities and separate layers. The MC layer is washed with MgSO 4 and 10 g of neutral activated carbon is added. The mixture is stirred for 30 minutes and then filtered. Recrystallization from methanol gave a solid (40% yield, 79%) of the title compound (40.5 g, 112 mmol)

(C) 2-아미노-9,9'-스피로비플루오렌의 합성: (화합물 3)(C) Synthesis of 2-amino-9,9'-spirobifluorene: (Compound 3)

상기 수득된 화합물2(40.5g)을 수소반응기에 넣고 IPA 500ml을 투입하고 RPM 450으로 교반한다. 60℃로 승온하여 상기 화합물이 완전히 녹는 것을 확인한 후 1g의 Pd-C 10%(wet 50%)를 넣고 H2(g)를 3기압을 유지하며 1시간 동안 반응한다. 여과하여 Pd-C를 제거한다. IPA를 100ml 정도 남을 때까지 농축하고 5℃정도 냉각하여 여과한다. IPE 100ml을 넣고 1시간 동안 환류한 후 상온 냉각하여 여과하여 표제화합물 33.8g(102 mmol)의 고체를 얻었다.(수율 91%)The obtained Compound 2 (40.5 g) was placed in a hydrogenation reactor, 500 ml of IPA was added, and the mixture was stirred with RPM 450. After confirming that the compound is completely dissolved, 1 g of Pd-C 10% (wet 50%) is added and H 2 (g) is maintained at 3 atm for 1 hour. Filter to remove Pd-C. Concentrate IPA to the extent of about 100 ml, cool it to about 5 ℃ and filter. 100 ml of IPE was added and the mixture was refluxed for 1 hour, cooled at room temperature and filtered to obtain 33.8 g (102 mmol) of the title compound (yield: 91%).

(D) N-비페닐-4-일-스피로비플루오렌-2-아민의 합성: (화합물 4)(D) Synthesis of N-biphenyl-4-yl-spirobifluorene-2-amine: (Compound 4)

상기 수득된 화합물3(33.8g)과 4-브로모비페닐 15.8g(68 mmol), 톨루엔 200ml를 500ml 삼구플라스크에 넣고 1시간 교반한다. 교반후 t-BuONa(sodium tert butoxide) 8g을 넣고 30분 교반한다. 교반 후 Pd(dba)2 2g을 넣고 30분 교반 후 Tri(t-butyl)Phosphine 2g을 넣고 60℃에서 6시간 반응한다. 반응 후 여과하고 물 200ml를 넣고 층분리한 후 톨루엔 층을 MgSO4를 이용하여 물을 제거하고, 중성활성탄 5.8g을 투입하여 30분 교반 후 여과 농축한다. 메탄올로 재결정하여 표제화합물 24.7g(51 mmol)의 고체를 얻었다.(수율 75%)(33.8 g) obtained above, 15.8 g (68 mmol) of 4-bromobiphenyl and 200 ml of toluene were placed in a 500 ml three-necked flask and stirred for 1 hour. After stirring, add 8 g of t-BuONa (sodium tert butoxide) and stir for 30 minutes. After stirring, add 2 g of Pd (dba) 2 , stir for 30 minutes, add 2 g of Tri (t-butyl) Phosphine and react at 60 ℃ for 6 hours. After filtration, 200 ml of water is added and the layers are separated. The toluene layer is washed with MgSO 4 to remove water, and 5.8 g of neutral activated carbon is added. After stirring for 30 minutes, the filtrate is concentrated. And recrystallized from methanol to obtain 24.7 g (51 mmol) of the title compound (yield: 75%).

(E) N-비페닐-4-일-N-(4-(9-페닐-9H- 카바졸 -3-일)-페닐)- 스피로비플루오렌 -2-아민의 합성: (화합물 5) (E) N- biphenyl-4-yl -N- (4- (9- phenyl -9H- carbazol-3-yl) phenyl) RY lobby fluorene-2-amine Synthesis of (Compound 5)

상기 수득된 화합물4(24.7g)과 3-(4-브로모페닐)-9-페닐-9H-카바졸 20.2g, 톨루엔 350ml를 500ml 삼구플라스크에 넣고 1시간 교반한다. 교반후 sodium tert butoxide 6g을 넣고 30분 교반한다. 교반 후 Pd(dba)2 촉매 2g을 넣고 30분 교반 후 Tri(t-butyl)Phosphine 2g 넣고 80℃에서 8시간 반응한다. 반응 후 여과하고 물 300ml를 넣고 층분리한 후 톨루엔 층을 MgSO4를 이용하여 물을 제거하고, 중성활성탄 6.3g을 투입하여 30분 교반 후 여과 농축한다. 메탄올로 재결정하여 고체의 표제화합물 32.3g(40 mmol)의 고체를 얻었다.(수율 79%)20.2 g of the obtained compound 4 (24.7 g), 3- (4-bromophenyl) -9-phenyl-9H-carbazole and 350 ml of toluene were placed in a 500 ml three-necked flask and stirred for 1 hour. After stirring, add 6 g of sodium tert butoxide and stir for 30 minutes. After stirring, add 2 g of Pd (dba) 2 catalyst, stir for 30 minutes, add 2 g of Tri (t-butyl) Phosphine and react at 80 ℃ for 8 hours. After the reaction, the reaction mixture is filtered and 300 ml of water is added thereto. The toluene layer is washed with MgSO 4 , and 6.3 g of neutral activated carbon is added. The reaction mixture is stirred for 30 minutes and then filtered. And recrystallized from methanol to obtain 32.3 g (40 mmol) of the solid title compound (yield: 79%).

실시예 2: N-비페닐-4-일-N-(4-(9- 페닐카바졸 -3-일)-페닐)- 스피로(9H-플루오 렌-9,9-9H-크산텐)의 합성: (화합물 10) Example 2: Synthesis of N-biphenyl-4-yl-N- (4- (9- phenylcarbazol- 3-yl) -phenyl) -spiro (9H- fluorene-9,9- Synthesis: (Compound 10)

하기 반응식 3에 따라 합성을 진행하였다.Synthesis was carried out according to Reaction Scheme 3 below.

[반응식 3][Reaction Scheme 3]

Figure pat00012
Figure pat00012

(A) 스피로(9H-플루오렌-9,9'-9H-크산텐)의 합성: (화합물 6)(A) Spiro (9H-fluorene-9,9'-9H-xanthene): (Compound 6)

크산톤(Xanthone) 39.2g(200 mmol)과 2-브로모비페닐 46.4g(200 mmol)을 상기 실시예 1의 (A)단계와 동일한 방법으로 반응시켜 표제화합물 45.8g(138 mmol)의 고체를 얻었다.(수율: 69%)39.2 g (200 mmol) of Xanthone and 46.4 g (200 mmol) of 2-bromobiphenyl were reacted in the same manner as in the step (A) of Example 1 to obtain 45.8 g (138 mmol) of the title compound as a solid (Yield: 69%).

(B) 스피로(2-니트로-9H-플루오렌-9,9-9H-크산텐)의 합성: (화합물 7)(B) Spiro (2-nitro-9H-fluorene-9,9-9H-xanthene) (Compound 7)

상기 수득된 화합물6(45.8g)을 상기 실시예 1의 (B)단계와 동일한 방법으로 반응시켜 표제화합물 37.9g(100 mmol)의 고체를 얻었다.(수율: 73%)The obtained compound 6 (45.8 g) was reacted in the same manner as in the step (B) of the above Example 1 to obtain 37.9 g (100 mmol) of the title compound (yield: 73%

(C) 스피로(2-아미노-9H-플루오렌-9,9-9H-크산텐)의 합성: (화합물 8)(C) Synthesis of Spiro (2-amino-9H-fluorene-9,9-9H-xanthene) (Compound 8)

상기 수득된 화합물7(37.9g)을 상기 실시예 1의 (C)단계와 동일한 방법으로 반응시켜 표제화합물 39.7g(86 mmol)의 고체를 얻었다.(수율: 85%)The obtained compound 7 (37.9 g) was reacted in the same manner as in the step (C) of Example 1 to obtain 39.7 g (86 mmol) of the title compound as a white solid (yield: 85%).

(D) N-비페닐-4-일- 스피로 (9H- 플루오렌 -9,9-9H-크산텐)-2- 아민의 합성: (화합물 9) Synthesis of N-biphenyl-4-yl- spiro (9H- fluorene- 9,9- 9H -xanthene) -2- amine : (Compound 9)

상기 수득된 화합물8(39.7g)과 4-브로모비페닐 13.2g(57 mmol)을 상기 실시예 1의 (D)단계와 동일한 방법으로 반응시켜 표제화합물 20.8g(41 mmol)의 고체를 얻었다.(수율: 73%)The compound 8 (39.7 g) obtained above and 13.2 g (57 mmol) of 4-bromobiphenyl were reacted in the same manner as in the step (D) of Example 1 to obtain a solid (20.8 g, 41 mmol) of the title compound. (Yield: 73%)

(E) N-비페닐-4-일-N-(4-(9- 페닐카바졸 -3-일)-페닐)- 스피로(9H-플루오렌-9,9-9H-크산텐)의 합성: (화합물 10) Synthesis of N-biphenyl-4-yl-N- (4- (9- phenylcarbazol- 3-yl) -phenyl) -spiro (9H-fluorene- 9,9-9H-xanthene) : (Compound 10)

상기 수득된 화합물9(20.8g)과 3-(4-브로모페닐)-9-페닐-9H-카바졸 16.3g을 상기 실시예 1의 (E)단계와 동일한 방법으로 반응시켜 표제화합물 25.5g(31 mmol)의 고체를 얻었다.(수율: 75%)The obtained Compound 9 (20.8 g) and 3- (4-bromophenyl) -9-phenyl-9H-carbazole (16.3 g) were reacted in the same manner as in the step (E) of Example 1 to give the title compound (31 mmol) of a solid (yield: 75%).

실시예 3: N-페닐-N-(4-(9- 페닐카바졸 -3-일)-비페닐)-4'-일- 스피로 (9,10- 하이드로-10,10-디메틸안트라센)-(9,9-9H-플루오렌)-2'-아민의 합성의 합성: (화합물 15) Example 3: N- phenyl -N- (4- (9- phenyl-carbazol-3-yl) biphenyl) -4'-yl-spiro (9,10-dihydro-anthracene -10,10- dimethyl) - (9,9-9H-fluorene) -2'-amine: (Compound 15)

하기 반응식 4에 따라 합성을 진행하였다.Synthesis was carried out according to Reaction Scheme 4 below.

[반응식 4][Reaction Scheme 4]

Figure pat00013
Figure pat00013

(A) 스피로 (9,10- 디하이드로 -10,10-디메틸안트라센-9,9-9H- 플루오렌 )의 합성: (화합물 11) (A) Synthesis of spiro (9,10 -dihydro- 10,10-dimethylanthracene - 9,9-9H- fluorene ) (Compound 11)

9,10-디하이드로-10,10-디메틸안트라센 44.4g(200 mmol)과 2-브로모비페닐 46.4g(200 mmol)을 상기 실시예 1의 (A)단계와 동일한 방법으로 반응시켜 표제화합물 45.8g(128 mmol)의 고체를 얻었다.(수율: 64%)44.4 g (200 mmol) of 9,10-dihydro-10,10-dimethyl anthracene and 46.4 g (200 mmol) of 2-bromobiphenyl were reacted in the same manner as in the step (A) of Example 1 to obtain the title compound 45.8 g (128 mmol) of a solid. (Yield: 64%).

(B) 스피로 (9,10- 디하이드로 -10,10-디메틸안트라센-9,9-9H-2-니트로- 플루오렌)의 합성: (화합물 12) (B) spiro-Synthesis of (9,10-dihydro-anthracene -10,10- dimethyl-2- nitro-fluoro -9,9-9H alkylene) (Compound 12)

상기 수득된 화합물11(45.8g)을 상기 실시예 1의 (B)단계와 동일한 방법으로 반응시켜 표제화합물 39.2g(97 mmol)의 고체를 얻었다.(수율: 76%)The obtained compound 11 (45.8 g) was reacted in the same manner as in the step (B) of Example 1 to obtain 39.2 g (97 mmol) of the title compound (yield: 76%).

(C) 스피로 (9,10- 디하이드로 -10,10-디메틸안트라센-9,9-9H-2-아미노- 플루오렌)의 합성: (화합물 13) (C) spiro - Synthesis of (9,10-dihydro-anthracene -10,10- dimethyl -9,9-9H-2- fluoro-amino butylene) (Compound 13)

상기 수득된 화합물12(39.2g)을 상기 실시예 1의 (C)단계와 동일한 방법으로 반응시켜 표제화합물 32.3g(87 mmol)의 고체를 얻었다.(수율: 89%)The obtained compound 12 (39.2 g) was reacted in the same manner as in the step (C) of Example 1 to obtain 32.3 g (87 mmol) of the title compound (yield: 89%).

(D) N-페닐- 스피로 (9,10- 디하이드로 -10,10-디메틸안트라센)-(9,9-9H- 플루오렌)-2'-아민의 합성: (화합물 14) (D) N- phenyl-spiro (9,10-dihydro-anthracene -10,10- dimethyl) - (fluoro 9,9-9H- alkylene) Synthesis of 2'-amine (Compound 14)

상기 수득된 화합물13(32.3g)과 4-브로모벤젠 8.9g(57 mmol)을 상기 실시예 1의 (D)단계와 동일한 방법으로 반응시켜 표제화합물 19.7g(44 mmol)의 고체를 얻었다.(수율: 76%)The obtained Compound 13 (32.3 g) and 8.9 g (57 mmol) of 4-bromobenzene were reacted in the same manner as in the step (D) of Example 1 to obtain 19.7 g (44 mmol) of the title compound as a solid. (Yield: 76%).

(E) N-페닐-N-(4-(9- 페닐카바졸 -3-일)-비페닐)-4'-일- 스피로 (9,10- 디하이드로-10,10-디메틸안트라센)-(9,9-9H-플루오렌)-2'-아민의 합성: (화합물 15) (E) N- phenyl -N- (4- (9- phenyl-carbazol-3-yl) biphenyl) -4'-yl-spiro (-10,10- dimethyl anthracene as 9,10-dihydroxy) - (9,9-9H-fluorene) -2'-amine: (Compound 15)

상기 수득된 화합물14(19.7g)과 3-(4‘-브로모-비페닐)-4-일-9-페닐-9H-카바졸 20.8g을 상기 실시예 1의 (E)단계와 동일한 방법으로 반응시켜 표제화합물 27.4g(33 mmol)의 고체를 얻었다.(수율: 74%)20.8 g of the obtained compound 14 (19.7 g) and 3- (4'-bromo-biphenyl) -4-yl-9-phenyl-9H- carbazole were reacted in the same manner as in step (E) To give 27.4 g (33 mmol) of the title compound as a white solid. (Yield: 74%).

실시예 4: N-페닐-N-(4-(9- 페닐카바졸 -3-일)-비페닐)-4'- yl - 스피로 (9H- 플로 오렌-9,9-9H-티오크산텐)-2-아민의 합성: (화합물 20) Example 4: N- phenyl -N- (4- (9- phenyl-carbazol-3-yl) -biphenyl) -4'- yl-spiro (9H- fluorene flow -9,9-9H- thioxanthene ) -2-amine: (Compound 20)

하기 반응식 5에 따라 합성을 진행하였다.The synthesis was carried out according to Reaction Scheme 5 below.

[반응식 5][Reaction Scheme 5]

Figure pat00014
Figure pat00014

(A) 스피로(9H-플루오렌-9,9'-9H-티오크산텐)의 합성: (화합물 16)(A) Spiro (9H-fluorene-9,9'-9H-thioxanthine): (Compound 16)

티오크산톤(Thioxanthone) 42.4g(200 mmol)과 2-브로모비페닐 46.4g(200 mmol)을 상기 실시예 1의 (A)단계와 동일한 방법으로 반응시켜 표제화합물 48.7g(140 mmol)의 고체를 얻었다.(수율: 70%)42.4 g (200 mmol) of thioxanthone and 46.4 g (200 mmol) of 2-bromobiphenyl were reacted in the same manner as in the step (A) of Example 1 to obtain 48.7 g (140 mmol) of the title compound (Yield: 70%).

(B) 스피로(2-니트로-9H-플루오렌-9,9'-9H-티오크산텐)의 합성: (화합물 17)(B) Spiro (2-nitro-9H-fluorene-9,9'-9H-thioxanthine): (Compound 17)

상기 수득된 화합물16(48.7g)을 상기 실시예 1의 (B)단계와 동일한 방법으로 반응시켜 표제화합물 42.4g(107 mmol)의 고체를 얻었다.(수율: 77%)The obtained Compound 16 (48.7 g) was reacted in the same manner as in the step (B) of Example 1 to obtain a solid (42.4 g, 107 mmol) of the title compound (yield: 77%).

(C) 스피로(2-아미노-9H-플루오렌-9,9'-9H-티오크산텐)의 합성: (화합물 18)(C) Synthesis of spiro (2-amino-9H-fluorene-9,9'-9H-thioxanthine) (Compound 18)

상기 수득된 화합물17(42.4g)을 상기 실시예 1의 (C)단계와 동일한 방법으로 반응시켜 표제화합물 35.6g(91 mmol)의 고체를 얻었다.(수율: 84%)The obtained compound 17 (42.4 g) was reacted in the same manner as in the step (C) of Example 1 to obtain a solid (35.6 g, 91 mmol) of the title compound (yield: 84%).

*(D) N-페닐- 스피로 (9H- 플로오렌 -9,9-9H- 티오크산텐 )-2- 아민의 합성: (화합물 19) (D) Synthesis of N-phenyl- spiro (9H- fluorene- 9,9-9H -thioxanthien ) -2- amine : (Compound 19)

상기 수득된 화합물18(35.6g)과 4-브로모벤젠 9.4g(60 mmol)을 상기 실시예 1의 (D)단계와 동일한 방법으로 반응시켜 표제화합물 19.6g(45 mmol)의 고체를 얻었다.(수율: 74%)The compound 18 (35.6 g) obtained above and 9.4 g (60 mmol) of 4-bromobenzene were reacted in the same manner as in the step (D) of Example 1 to obtain 19.6 g (45 mmol) of the title compound as a solid. (Yield: 74%).

(E) N-페닐-N-(4-(9- 페닐카바졸 -3-일)-비페닐)-4'- yl - 스피로 (9H- 플로오렌 -9,9-9H-티오크산텐)-2-아민의 합성: (화합물 20) (E) N- phenyl -N- (4- (9- phenyl-carbazol-3-yl) -biphenyl) -4'- yl-spiro (9H- fluorene flow-9,9-9H- thioxanthene) -2-amine: (Compound 20)

상기 수득된 화합물19(19.6g)과 3-(4‘-브로모-비페닐)-4-일-9-페닐-9H-카바졸 21.2g을 상기 실시예 1의 (E)단계와 동일한 방법으로 반응시켜 표제화합물 28.6g(34 mmol)의 고체를 얻었다.(수율: 77%)9.2 g of the obtained compound 19 (19.6 g) and 3- (4'-bromo-biphenyl) -4-yl-9-phenyl-9H- carbazole were reacted in the same manner as in the step (E) To obtain 28.6 g (34 mmol) of the title compound as a solid. (Yield: 77%).

실시예 5: N-9,9-디메틸- 플루오렌 -2-일-N-(4-(9- 페닐카바졸 -3-일)-페닐)- 피로(10,11-디하이드로-5H-디벤조[a,d]시클로헵텐-5,9'-플루오렌)-2'-아민의 합성: (화합물 25) Example 5: N-9,9- dimethyl-fluorene-2-yl -N- (4- (9- phenyl-carbazol-3-yl) phenyl)'s fatigue (10,11-dihydro -5H -Dibenzo [a, d] cycloheptene-5,9'-fluorene) -2'-amine: (Compound 25)

하기 반응식 6에 따라 합성을 진행하였다.Synthesis was carried out according to Scheme 6 below.

[반응식 6][Reaction Scheme 6]

Figure pat00015
Figure pat00015

(A) 스피로(10,11-디메틸-5H-디벤조[a,d]시클로헵텐 -5,9'- 플루오렌 )의 합성: (화합물 21) (A) Synthesis of spiro (10,11-dimethyl -5H- dibenzo [a, d] cycloheptene -5,9'- fluorene): (Compound 21)

10,11-디메틸-디벤조수베론(Dibenzosuberone) 52.8g(200 mmol)과 2-브로모비페닐 46.4g(200 mmol)을 상기 실시예 1의 (A)단계와 동일한 방법으로 반응시켜 표제화합물 43.2g(108 mmol)의 고체를 얻었다.(수율: 54%)52.8 g (200 mmol) of 10,11-dimethyl-dibenzosuberone and 46.4 g (200 mmol) of 2-bromobiphenyl were reacted in the same manner as in the step (A) of Example 1 to obtain the title compound 43.2 g (108 mmol) of a solid (yield: 54%).

(B) 스피로(10,11-디메틸-5H-디벤조[a,d]시클로헵텐 -2-니트로-5,9'- 플루오렌)의 합성: (화합물 22) (B) Synthesis of spiro (10,11-dimethyl -5H- dibenzo [a, d] cycloheptene-2-nitro-fluoro -5,9'- alkylene) (Compound 22)

상기 수득된 화합물21(43.2g)을 상기 실시예 1의 (B)단계와 동일한 방법으로 반응시켜 표제화합물 34.6g(78 mmol)의 고체를 얻었다.(수율: 72%)The obtained compound 21 (43.2 g) was reacted in the same manner as in the step (B) of Example 1 to obtain 34.6 g (78 mmol) of the title compound (yield: 72%).

(C) 스피로 (10,11-디메틸-5H- 디벤조[a,d]시클로헵텐 -5,9'- 플루오렌 )-2'- 아민의 합성: (화합물 23) (C) spiro (10,11-dimethyl -5H- dibenzo [a, d] cycloheptene -5,9'- fluorene) Synthesis of 2'-amine (compound 23)

상기 수득된 화합물22(34.6g)을 상기 실시예 1의 (C)단계와 동일한 방법으로 반응시켜 표제화합물 27.8g(67 mmol)의 고체를 얻었다.(수율: 86%)The obtained compound 22 (34.6 g) was reacted in the same manner as in the step (C) of Example 1 to obtain 27.8 g (67 mmol) of the title compound as a white solid (yield: 86%).

(D) N-9,9-디메틸- 플루오렌 -2-일- 스피로 (10,11-디메틸-5H- 디벤조[a,d]시클로헵텐-5,9'-플루오렌)-2'-아민의 합성: (화합물 24) (D) N-9,9-dimethyl- fluoren -2-yl- spiro (10,11-dimethyl- 5H- dibenzo [a, d] cycloheptene- Synthesis of amine: (Compound 24)

상기 수득된 화합물23(27.8g)과 2-브로모-9,9-디메틸-9H-플루오렌 12.3g(45 mmol)을 상기 실시예 1의 (D)단계와 동일한 방법으로 반응시켜 표제화합물 19.5g(32 mmol)의 고체를 얻었다.(수율: 72%)The obtained compound 23 (27.8 g) and 2-bromo-9,9-dimethyl-9H-fluorene 12.3 g (45 mmol) were reacted in the same manner as in the step (D) of Example 1 to obtain the title compound 19.5 g (32 mmol) of a solid. (Yield: 72%).

(E) N-9,9-디메틸- 플루오렌 -2-일-N-(4-(9- 페닐카바졸 -3-일)-페닐)- 스피로(10,11-디메틸-5H-디벤조[a,d]시클로헵텐-5,9'-플루오렌)-2'-아민의 합성: (화합물 25) (E) N-9,9- dimethyl-fluorene-2-yl -N- (4- (9- phenyl-carbazol-3-yl) phenyl) as a spigot (10,11-dimethyl-di -5H- Benzo [a, d] cycloheptene-5,9'-fluorene) -2'-amine: (Compound 25)

상기 수득된 화합물24(19.5g)과 3-(4-브로모페닐)-9-페닐-9H-카바졸 12.7g을 상기 실시예 1의 (E)단계와 동일한 방법으로 반응시켜 표제화합물 23.7g(27 mmol)의 고체를 얻었다.(수율: 80%)The compound 24 (19.5 g) obtained above and 12.7 g of 3- (4-bromophenyl) -9-phenyl-9H-carbazole were reacted in the same manner as in the step (E) of Example 1 to give 23.7 g (27 mmol) of a solid (yield: 80%).

실시예 6: N-9,9-디메틸- 플루오렌 -2-일-N-(4-(9- 페닐카바졸 -3-일)-페닐)- 피로(5H-디벤조[a,d]시클로헵텐-5,9'-플루오렌)-2'-아민의 합성: (화합물 30) Example 6: N-9,9- dimethyl-fluorene-2-yl -N- (4- (9- phenyl-carbazol-3-yl) phenyl)'s fatigue (5H- dibenzo [a, d ] Cycloheptene-5,9'-fluorene) -2'-amine: (Compound 30)

하기 반응식 7에 따라 합성을 진행하였다.Synthesis was carried out according to Scheme 7 below.

[반응식 7][Reaction Scheme 7]

Figure pat00016
Figure pat00016

(A) 스피로(5H-디벤조[a,d]시클로헵텐-5,9'-플루오렌)의 합성: (화합물 26) ( A) Spiro (5H-dibenzo [a, d] cycloheptene-5,9'-fluorene) (Compound 26)

5H-디벤조[a,d]시클로헵텐-온 41.2g(200 mmol)과 2-브로모비페닐 46.4g(200 mmol)을 상기 실시예 1의 (A)단계와 동일한 방법으로 반응시켜 표제화합물 40.1g(122 mmol)의 고체를 얻었다.(수율: 61%)41.2 g (200 mmol) of 5H-dibenzo [a, d] cycloheptenone and 46.4 g (200 mmol) of 2-bromobiphenyl were reacted in the same manner as in the step (A) g (122 mmol) of a solid (yield: 61%).

(B) 스피로(5H-디벤조[a,d]시클로헵텐 -2-니트로-5,9'- 플루오렌 )의 합성의 합성: (화합물 27) (B) spiro synthesis of: Synthesis of (5H- dibenzo [a, d] cycloheptene-2-nitro -5,9'- fluorene): (Compound 27)

상기 수득된 화합물26(40.1g)을 상기 실시예 1의 (B)단계와 동일한 방법으로 반응시켜 표제화합물 35.9g(93 mmol)의 고체를 얻었다.(수율: 76%)The obtained compound 26 (40.1 g) was reacted in the same manner as in the step (B) of Example 1 to obtain 35.9 g (93 mmol) of the title compound as a white solid (yield: 76%).

(C) 스피로 (5H- 디벤조[a,d]시클로헵텐 -5,9'- 플루오렌 )-2'- 아민의 합성: (화합물 28) (C) spiro (5H- dibenzo [a, d] cycloheptene -5,9'- fluorene) Synthesis of 2'-amine (compound 28 screen)

상기 수득된 화합물27(35.9g)을 상기 실시예 1의 (C)단계와 동일한 방법으로 반응시켜 표제화합물 26.8g(75 mmol)의 고체를 얻었다.(수율: 81%)The obtained compound 27 (35.9 g) was reacted in the same manner as in the step (C) of Example 1 to obtain 26.8 g (75 mmol) of the title compound (yield: 81%).

(D) N-9,9-디메틸- 플루오렌 -2-일- 스피로 (5H- 디벤조[a,d]시클로헵텐 -5,9'- 루오렌)-2'-아민의 합성의 합성: (화합물 29) (D) N-9,9- dimethyl-fluorene-2-yl-spiro (5H- dibenzo [a, d] cycloheptene -5,9'- flat base fluorene) Synthesis of 2'-amine : (Compound 29)

상기 수득된 화합물28(26.8g)과 2-브로모-9,9-디메틸-9H-플루오렌 13.6g(50 mmol)을 상기 실시예 1의 (D)단계와 동일한 방법으로 반응시켜 표제화합물 19.0g(35 mmol)의 고체를 얻었다.(수율: 69%)The compound 28 (26.8 g) obtained above and 13.6 g (50 mmol) of 2-bromo-9,9-dimethyl-9H-fluorene were reacted in the same manner as in the step (D) of Example 1 to obtain the title compound 19.0 g (35 mmol) of a solid (yield: 69%).

(E) N-9,9-디메틸- 플루오렌 -2-일-N-(4-(9- 페닐카바졸 -3-일)-페닐)- 스피로(5H-디벤조[a,d]시클로헵텐-5,9'-플루오렌)-2'-아민의 합성: (화합물 30) (E) N-9,9- dimethyl-fluorene-2-yl -N- (4- (9- phenyl-carbazol-3-yl) phenyl) as a spigot (5H- dibenzo [a, d] Cycloheptene-5,9'-fluorene) -2'-amine: (Compound 30)

상기 수득된 화합물29(19.0g)과 3-(4-브로모페닐)-9-페닐-9H-카바졸 13.9g을 상기 실시예 1의 (E)단계와 동일한 방법으로 반응시켜 표제화합물 21.2g(26 mmol)의 고체를 얻었다.(수율: 72%)The obtained compound 29 (19.0 g) and 3- (4-bromophenyl) -9-phenyl-9H-carbazole 13.9 g were reacted in the same manner as in the step (E) of Example 1 to give 21.2 g (26 mmol) of a solid (yield: 72%).

실시예 7: N-페닐-N-(7-(9- 페닐카바졸 -3-일)-9,9-디메틸-9H- 플루오렌 )-2-일- 스피로(10-메틸-10H-아크리딘-9,9-9H-플루오렌)-2'-아민의 합성: (화합물 35) Example 7: N- phenyl -N- (7- (9- phenyl-carbazol-3-yl) 9,9-dimethyl -9H- fluorene) -2-yl-spiro (10-O-methyl -10H- 9,9-9H-fluorene) -2'-amine: (Compound 35)

하기 반응식 8에 따라 합성을 진행하였다.Synthesis was carried out according to Scheme 8 below.

[반응식 8][Reaction Scheme 8]

Figure pat00017
Figure pat00017

(A) 스피로(10-메틸-10H-아크리딘-9,9-9H-플루오렌)의 합성: (화합물 31)(A) Spiro (10-methyl-10H-acridine-9,9-9H-fluorene) (Compound 31)

10-메틸아크리딘-9-10H-온 41.8g(200 mmol)과 2-브로모비페닐 46.4g(200 mmol)을 상기 실시예 1의 (A)단계와 동일한 방법으로 반응시켜 표제화합물 48.3g(140 mmol)의 고체를 얻었다.(수율: 70%)(200 mmol) of 2-bromobiphenyl and 46.4 g (200 mmol) of 2-bromobiphenyl were reacted in the same manner as in the step (A) of Example 1 to give 48.3 g (140 mmol) of the title compound. (Yield: 70%).

(B) 스피로 (10- 메틸 -10H-아크리딘-2-니트로-9,9-9H- 플루오렌 )의 합성: (화합물 32) (B) Spiro (10- methyl- 10H-acridine-2-nitro-9,9-9H- fluorene ) (Compound 32)

상기 수득된 화합물31(43.8g)을 상기 실시예 1의 (B)단계와 동일한 방법으로 반응시켜 표제화합물 42.0g(108 mmol)의 고체를 얻었다.(수율: 77%)The obtained Compound 31 (43.8 g) was reacted in the same manner as in the step (B) of Example 1 to obtain 42.0 g (108 mmol) of the title compound as a white solid. (Yield: 77%

(C) 스피로 (10- 메틸 -10H-아크리딘-9,9-9H- 플루오렌 )-2'- 아민의 합성: (화합물 33) (C) spiro (10-methyl-acridine -10H- -9,9-9H- fluorene) Synthesis of 2'-amine (compounds 33)

상기 수득된 화합물32(42.0g)을 상기 실시예 1의 (C)단계와 동일한 방법으로 반응시켜 표제화합물 34.5g(96 mmol)의 고체를 얻었다.(수율: 89%)The obtained compound 32 (42.0 g) was reacted in the same manner as in the step (C) of Example 1 to obtain 34.5 g (96 mmol) of the title compound (yield: 89%).

(D) N-페닐- 스피로 (10- 메틸 -10H-아크리딘-9,9-9H- 플루오렌 )-2'- 아민의 합성: (화합물 34) (D) N- phenyl-spiro (10-methyl-acridine -10H- -9,9-9H- fluorene) Synthesis of 2'-amine (Compound 34)

상기 수득된 화합물33(34.5g)과 4-브로모벤젠 9.9g(64 mmol)을 상기 실시예 1의 (D)단계와 동일한 방법으로 반응시켜 표제화합물 18.7g(43 mmol)의 고체를 얻었다.(수율: 67%)The compound 33 (34.5 g) obtained above and 9.9 g (64 mmol) of 4-bromobenzene were reacted in the same manner as in the step (D) of Example 1 to obtain 18.7 g (43 mmol) of the title compound. (Yield: 67%).

(E) N-페닐-N-(7-(9- 페닐카바졸 -3-일)-9,9-디메틸-9H- 플루오렌 )-2-일- 스피로(10-메틸-10H-아크리딘-9,9-9H-플루오렌)-2'-아민의 합성: (화합물 35) (E) N- phenyl -N- (7- (9- phenyl-carbazol-3-yl) 9,9-dimethyl -9H- fluorene) -2-yl-in spigot (10-O-methyl -10H- 9,9-9H-fluorene) -2'-amine: (Compound 35)

상기 수득된 화합물34(18.7g)과 3-(7-브로모-9,9-디메틸-9H-플루오렌-2-일)-9-페닐-9H-카바졸 22.0g을 상기 실시예 1의 (E)단계와 동일한 방법으로 반응시켜 표제화합물 28.3g(33 mmol)의 고체를 얻었다.(수율: 76%)22.0 g of the obtained compound 34 (18.7 g) and 3- (7-bromo-9,9-dimethyl-9H-fluoren-2-yl) (E), 28.3 g (33 mmol) of the title compound was obtained (yield: 76%).

실시예 8: N-페닐-N-(7-(9- 페닐카바졸 -3-일)-9,9-디메틸-9H- 플루오렌 )-2-일- 스피로(안트라센-10-온-9,9-9H-플루오렌)-2'-아민의 합성: (화합물 40) Example 8: N- phenyl -N- (7- (9- phenyl-carbazol-3-yl) 9,9-dimethyl -9H- fluorene) -2-yl-spiro (anthracene-10-on--9 , 9-9H-fluorene) -2'-amine: (Compound 40)

하기 반응식 9에 따라 합성을 진행하였다.Synthesis was carried out according to Scheme 9 below.

[반응식 9][Reaction Scheme 9]

Figure pat00018
Figure pat00018

(A) 스피로(안트라센-10-온-9,9-9H-플루오렌)의 합성: (화합물 36)(A) Synthesis of spiro (anthracene-10-one-9,9-9H-fluorene) (Compound 36)

안트라퀴논 41.6g(200 mmol)과 2-브로모비페닐 46.4g(200 mmol)을 상기 실시예 1의 (A)단계와 동일한 방법으로 반응시켜 표제화합물 44.0g(128 mmol)의 고체를 얻었다.(수율: 64%)41.6 g (200 mmol) of anthraquinone and 46.4 g (200 mmol) of 2-bromobiphenyl were reacted in the same manner as in the step (A) of Example 1 to obtain 44.0 g (128 mmol) of the title compound Yield: 64%)

(B) 스피로 (9H-안트라센-10-온-2-니트로-9,9-9H- 플루오렌 )의 합성: (화합물 37) (B) Spiro (9H-anthracene-10-one-2-nitro-9,9-9H- fluorene ) (Compound 37)

상기 수득된 화합물36(44.0g)을 상기 실시예 1의 (B)단계와 동일한 방법으로 반응시켜 표제화합물 35.9g(92 mmol)의 고체를 얻었다.(수율: 72%)The obtained Compound 36 (44.0 g) was reacted in the same manner as in the step (B) of Example 1 to obtain 35.9 g (92 mmol) of the title compound as a white solid. (Yield: 72%

(C) 스피로(안트라센-10-온-9,9-9H-플루오렌)-2'-아민의 합성: (화합물 38)(C) Synthesis of spiro (anthracene-10-one-9,9-9H-fluorene) -2'-amine: (Compound 38)

상기 수득된 화합물37(35.9g)을 상기 실시예 1의 (C)단계와 동일한 방법으로 반응시켜 표제화합물 26.5g(73 mmol)의 고체를 얻었다.(수율: 80%)The obtained compound 37 (35.9 g) was reacted in the same manner as in the step (C) of Example 1 to obtain a solid (26.5 g, 73 mmol) of the title compound (yield: 80%).

*(D) N-페닐- 스피로 (안트라센-10-온-9,9-9H- 플루오렌 )-2'- 아민의 합성: (화합물 39)* (D), N- phenyl-spiro (anthracene-10-on--9,9-9H- fluorene) Synthesis of 2'-amine (compounds 39)

상기 수득된 화합물38(26.5g)과 4-브로모벤젠 7.6g(49 mmol)을 상기 실시예 1의 (D)단계와 동일한 방법으로 반응시켜 표제화합물 15.4g(35 mmol)의 고체를 얻었다.(수율: 72%)The compound 38 (26.5 g) obtained above and 7.6 g (49 mmol) of 4-bromobenzene were reacted in the same manner as in the step (D) of Example 1 to obtain the title compound (15.4 g, 35 mmol). (Yield: 72%).

(E) N-페닐-N-(7-(9- 페닐카바졸 -3-일)-9,9-디메틸-9H- 플루오렌 )-2-일- 스피로(안트라센-10-온-9,9-9H-플루오렌)-2'-아민의 합성: (화합물 40) (E) N- phenyl -N- (7- (9- phenyl-carbazol-3-yl) 9,9-dimethyl -9H- fluorene) -2-yl-in spigot (anthracene-10-on--9 , 9-9H-fluorene) -2'-amine: (Compound 40)

상기 수득된 화합물39(15.4g)과 3-(7-브로모-9,9-디메틸-9H-플루오렌-2-일)-9-페닐-9H-카바졸 17.9g을 상기 실시예 1의 (E)단계와 동일한 방법으로 반응시켜 표제화합물 23.6g(27 mmol)의 고체를 얻었다.(수율: 77%)17.9 g of the obtained compound 39 (15.4 g) and 3- (7-bromo-9,9-dimethyl-9H-fluoren-2-yl) (E), 23.6 g (27 mmol) of the title compound was obtained (yield: 77%).

Claims (7)

하기 화학식 I로 표시되는 유기전계발광 소자 제조용 화합물.
[화학식 I]
Figure pat00019

(상기 식에서,
-Z-는 단일 결합(-), -CR5R6-, -CR5R6-CR5R6-, -CR5=CR6-, -O-, -S-, >N-R5 또는 >C=O이고,
R1, R2, R3, R4, R5 및 R6은 각각 독립적으로, 수소원자 또는 C1~C15의 직쇄 또는 측쇄 알킬기이고,
m, n, p, q는 각 벤젠고리의 치환 갯수로서 각각 독립적으로 0, 1, 2, 3 또는 4이고,
Ar1, Ar2는 각각 독립적으로, 치환되지 않거나 C1~C15의 직쇄 또는 측쇄 알킬기로 치환된 페닐기; 치환되지 않거나 C1~C15의 직쇄 또는 측쇄 알킬기로 치환된 비페닐기; 치환되지 않거나 C1~C15의 직쇄 또는 측쇄 알킬기로 치환된 플루오렌기이다.)
A compound for the production of an organic electroluminescent device represented by the following formula (I).
(I)
Figure pat00019

(Wherein,
-Z- represents a single bond (-), -CR 5 R 6 -, -CR 5 R 6 -CR 5 R 6 -, -CR 5 = CR 6 -, -O-, -S-,> NR 5 or> C = O,
R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are each independently a hydrogen atom or a C 1 to C 15 linear or branched alkyl group,
m, n, p, and q are independently the number of substituents of each benzene ring, 0, 1, 2, 3 or 4,
Ar 1 and Ar 2 are each independently a phenyl group which is unsubstituted or substituted with a C 1 to C 15 linear or branched alkyl group; A biphenyl group which is unsubstituted or substituted with a linear or branched alkyl group having 1 to 15 carbon atoms; A fluorene group which is unsubstituted or substituted by a C 1 -C 15 linear or branched alkyl group.)
제1항에 있어서,
하기 화학식 Ⅱ으로 표시되는 것인 유기전계발광 소자 제조용 화합물.
[화학식 Ⅱ]
Figure pat00020

(상기 식에서,
-Z-는 단일 결합(-), -CR5R6-, -CR5R6-CR5R6-, -CR5=CR6-, -O-, -S-, >N-R5 또는 >C=O이고,
점선은 존재하지 않거나 -CR10R11- 이고,
상기 R1, R2, R3, R4, R5, R6, R7, R8, R9, R10 및 R11 은 각각 독립적으로, 수소원자 또는 C1~C15의 직쇄 또는 측쇄 알킬기이고,
m, n, p, q, s, t는 각 벤젠고리의 치환 갯수로서 각각 독립적으로, 0, 1, 2, 3 또는 4이고, r은 0, 1, 2, 3, 4 또는 5이다.)
The method according to claim 1,
A compound for producing an organic electroluminescence device, which is represented by the following formula (II).
[Formula II]
Figure pat00020

(Wherein,
-Z- represents a single bond (-), -CR 5 R 6 -, -CR 5 R 6 -CR 5 R 6 -, -CR 5 = CR 6 -, -O-, -S-,> NR 5 or> C = O,
The dotted line is absent or -CR < 10 > R < 11 &
Each of R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 and R 11 is independently a hydrogen atom or a C 1 to C 15 linear or branched Alkyl group,
m, n, p, q, s, and t are independently 0, 1, 2, 3 or 4 and r is 0, 1, 2, 3, 4 or 5,
제1항에 있어서,
하기 화학식 Ⅲ으로 표시되는 것인 유기전계발광 소자 제조용 화합물.
[화학식 Ⅲ]
Figure pat00021

(상기 식에서,
-Z-는 단일 결합(-), -CR5R6-, -CR5R6-CR5R6-, -CR5=CR6-, -O-, -S-, >N-R5 또는 >C=O이고,
점선은 존재하지 않거나 -CR10R11- 이고,
상기 R1, R2, R3, R4, R5, R6, R7, R8, R9, R10 및 R11 은 각각 독립적으로, 수소원자 또는 C1~C15의 직쇄 또는 측쇄 알킬기이고,
m, n, p, q, s, t는 각 벤젠고리의 치환 갯수로서 각각 독립적으로, 0, 1, 2, 3 또는 4이고, r은 0, 1, 2, 3, 4 또는 5이다.)
The method according to claim 1,
A compound for the production of an organic electroluminescence device, which is represented by the following formula (III).
[Formula (III)
Figure pat00021

(Wherein,
-Z- represents a single bond (-), -CR 5 R 6 -, -CR 5 R 6 -CR 5 R 6 -, -CR 5 = CR 6 -, -O-, -S-,> NR 5 or> C = O,
The dotted line is absent or -CR < 10 > R < 11 &
Each of R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 and R 11 is independently a hydrogen atom or a C 1 to C 15 linear or branched Alkyl group,
m, n, p, q, s, and t are independently 0, 1, 2, 3 or 4 and r is 0, 1, 2, 3, 4 or 5,
제2항 또는 제3항에 있어서,
상기 R1, R2, R3, R4, R5, R6, R7, R8, R9, R10 및 R11 은 각각 독립적으로, 수소원자, 메틸기 또는 에틸기인 유기전계발광 소자 제조용 화합물.
The method according to claim 2 or 3,
Wherein R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 and R 11 are each independently a hydrogen atom, a methyl group or an ethyl group, compound.
제1항에 있어서,
상기 화합물은 하기 화학식들에서 이루어진 군에서 선택되는 것인 유기전계발광 소자 제조용 화합물.
Figure pat00022

Figure pat00023

Figure pat00024

Figure pat00025

Figure pat00026

Figure pat00027

Figure pat00028

Figure pat00029

(상기 식들에서,
점선은 존재하지 않거나 -C(CH3)2- 이고,
상기 R5, R6 및 R7은 각각 독립적으로 수소원자, 메틸기 또는 에틸기이고,
r은 각 벤젠고리의 치환 갯수로서 0, 1, 2, 3, 4 또는 5이다.)
The method according to claim 1,
Wherein the compound is selected from the group consisting of the following chemical formulas.
Figure pat00022

Figure pat00023

Figure pat00024

Figure pat00025

Figure pat00026

Figure pat00027

Figure pat00028

Figure pat00029

(In the above equations,
And, - the dotted line is not present or -C (CH 3) 2
R 5 , R 6 and R 7 are each independently a hydrogen atom, a methyl group or an ethyl group,
and r is 0, 1, 2, 3, 4 or 5 as the substitution number of each benzene ring.
제1항 내지 제5항 중 어느 한 항에 따른 화합물을 정공수송층에 포함하는 유기전계발광 소자.
An organic electroluminescent device comprising the compound according to any one of claims 1 to 5 in a hole transport layer.
제1항 내지 제5항 중 어느 한 항에 따른 화합물을 발광층에 포함하는 유기전계발광 소자.An organic electroluminescent device comprising a compound according to any one of claims 1 to 5 in a light emitting layer.
KR1020160106252A 2016-08-22 2016-08-22 Novel compounds for organic electroluminescent device KR20160102949A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020160106252A KR20160102949A (en) 2016-08-22 2016-08-22 Novel compounds for organic electroluminescent device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020160106252A KR20160102949A (en) 2016-08-22 2016-08-22 Novel compounds for organic electroluminescent device

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020120063549A Division KR20130140303A (en) 2012-06-14 2012-06-14 Novel compounds for organic electroluminescent device

Publications (1)

Publication Number Publication Date
KR20160102949A true KR20160102949A (en) 2016-08-31

Family

ID=56877451

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020160106252A KR20160102949A (en) 2016-08-22 2016-08-22 Novel compounds for organic electroluminescent device

Country Status (1)

Country Link
KR (1) KR20160102949A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018216903A1 (en) * 2017-05-22 2018-11-29 주식회사 엘지화학 Novel compound and organic light-emitting device using same
WO2018230782A1 (en) * 2017-06-14 2018-12-20 주식회사 두산 Organic compound and organic electroluminescent device comprising same
TWI658030B (en) * 2017-05-22 2019-05-01 南韓商Lg化學股份有限公司 Novel compound and organic light emitting device comprising the same
CN110944984A (en) * 2017-08-02 2020-03-31 株式会社Lg化学 Heterocyclic compound and organic light-emitting element comprising same
US11515478B2 (en) 2017-05-22 2022-11-29 Lg Chem Ltd. Compound and organic light emitting device using the same

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020510652A (en) * 2017-05-22 2020-04-09 エルジー・ケム・リミテッド Novel compound and organic light emitting device using the same
TWI658030B (en) * 2017-05-22 2019-05-01 南韓商Lg化學股份有限公司 Novel compound and organic light emitting device comprising the same
CN110382457A (en) * 2017-05-22 2019-10-25 株式会社Lg化学 New compound and the organic luminescent device using it
WO2018216903A1 (en) * 2017-05-22 2018-11-29 주식회사 엘지화학 Novel compound and organic light-emitting device using same
CN110382457B (en) * 2017-05-22 2022-06-14 株式会社Lg化学 Novel compound and organic light emitting device using the same
US11459290B2 (en) 2017-05-22 2022-10-04 Lg Chem, Ltd. Compound and organic light emitting device using the same
US11515478B2 (en) 2017-05-22 2022-11-29 Lg Chem Ltd. Compound and organic light emitting device using the same
WO2018230782A1 (en) * 2017-06-14 2018-12-20 주식회사 두산 Organic compound and organic electroluminescent device comprising same
KR20180136218A (en) * 2017-06-14 2018-12-24 주식회사 두산 Organic compounds and organic electro luminescence device comprising the same
JP2020524668A (en) * 2017-06-14 2020-08-20 トゥサン ソーラス カンパニー リミテッドDoosan Solus Co., Ltd. Organic compound and organic electroluminescent device containing the same
CN110944984A (en) * 2017-08-02 2020-03-31 株式会社Lg化学 Heterocyclic compound and organic light-emitting element comprising same
US11634414B2 (en) 2017-08-02 2023-04-25 Lg Chem, Ltd. Heterocyclic compound and organic light-emitting element including same
CN110944984B (en) * 2017-08-02 2023-09-08 株式会社Lg化学 Heterocyclic compound and organic light-emitting element comprising same

Similar Documents

Publication Publication Date Title
KR20130140303A (en) Novel compounds for organic electroluminescent device
JP6522829B2 (en) Synthetic method
KR101771531B1 (en) Spiro compound and organic electroluminescent devices comprising the same
KR101216004B1 (en) Anthracene derivatives and organic light-emitting diode including the same
TWI602800B (en) Indenotriphenylene-based amine derivative and organic electroluminescence device using the same
TWI477488B (en) Compound for organic electronic element, organic electronic element using the same, and electronic device thereof
JP3848296B2 (en) Organic light emitting diode
JP2021022733A (en) Organic light emitting device containing boron compound
KR101996649B1 (en) Pyrene derivative compounds and organic light-emitting diode including the same
KR101861263B1 (en) Anthracene deriva tives and organic light-emitting diode including the same
KR20160102949A (en) Novel compounds for organic electroluminescent device
KR20100066424A (en) Anthracene derivatives and organoelectroluminescent device including the same
TW201313680A (en) New compounds and organic light emitting device using the same
TW201323410A (en) Spirobifluorene compounds for light emitting devices
WO2008026614A1 (en) Method for synthesizing anthracene derivative and anthracene derivative, light emitting element, light emitting device, electronic device
KR101793428B1 (en) Condensed aryl compounds and organic light-diode including the same
KR100910134B1 (en) Organic luminescent material and organic light emitting device using the same
KR20130007495A (en) Host compounds and organic electroluminescent device using the same
KR20160127503A (en) triazine derivatives and organic electroluminescent device including the same
TWI465441B (en) Imidazole derivatives having vinyl group and its use in electroluminescent element
KR101779915B1 (en) Fused arylamine compound and organic electroluminescent devices comprising the same
JP2004175691A (en) Phenanthroline derivative, method for producing the same derivative and application thereof
KR102004385B1 (en) New compounds and organic light-emitting diode including the same
KR101759481B1 (en) Spiro compound and organic electroluminescent devices comprising the same
TW201947013A (en) Heteroaromatic compound and organic electroluminescence device using the same

Legal Events

Date Code Title Description
A107 Divisional application of patent
E902 Notification of reason for refusal
E601 Decision to refuse application